Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


2nd Annual World Orphan Drug Congress 2012

17 Oct 2012 - 18 Oct 2012 - Barcelona, Spain



Bookmark and Share


In order to discuss major concerns, the newest solutions and challenges connected with prevention, diagnosis and treatment of rare diseases, Fleming Europe has organized its 2nd Annual Orphan Drug Congress 2012. On 17 – 18 October 2012 the top-level pharmaceutical experts in orphan drug development, regulatory affairs & pricing will gather in Barcelona to discuss this year's critical issues.

Focused interactive discussions integrated between individual presentation blocks will provide enough space and a unique opportunity to exchange ideas with industry peers and get the answers from our speakers.

The attendees will have the opportunity to:

  • Understand the infrastructure in order to gain approval in emerging markets 
  • Gain critical insights behind the successful development, authorization and  reimbursement of rare disease drugs 
  • Find out how to regulate the use of social media for orphan drugs & rare diseases 
  • Explore the importance of communication Between Pharma, Patient & HTA Bodies 
  • Meet the top executives and experts from leading pharmaceutical companies as well as  from medium and small pharma companies with the focus on rare and neglected    diseases

For further details please request the event brochure http://pharma.flemingeurope.com/orphan-drug-congress/request-agenda




Further information
Scientific News
Rates of Nonmedical Prescription Opioid Use Disorder Double in 10 Years
Researchers at NIH have found that the nonmedical use of prescription opioids has more than doubled among adults in the United States from 2001-2002 to 2012-2013.
Self-Assembling Protein Shell for Drug Delivery
Made-to-order nano-cages open possibilities of shipping cargo into living cells or fashioning small chemical reactors.
Guided Chemotherapy Missiles
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
‘Human-on-a-Chip’ Could Replace Animal Testing
Researchers are developing a “human-on-a-chip,” a miniature external replication of the human body, integrating biology and engineering with a combination of microfluidics and multi-electrode arrays.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
‘Missing Tooth’ Hydrogels Handle Hard-to-Deliver Drugs
Rice University’s custom hydrogel traps water-avoiding molecules for slow delivery.
Copper is Key in Burning Fat
Berkeley Lab scientist says results could provide new target for obesity research.
Better Animal Model to Improve HIV Vaccine Development
Penn study identifies a new tool to produce better HIV vaccine designs.
Identifying Side-Effects At Early Stages Of Drug Development
An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline (GSK).
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!